Department of Medicine faculty have received notice of the following research, clinical trials, CME or other training awards.
[tabs style="vertical"] [tab title="Sponsored research"]Jason Allen of Cardiology has received an award (1R21-HL111972-01) from the National Institutes of Health for a project entitled "Increased Plasma Nitrite, Tissue Oxygenation and Functional Changes in PAD." Total funding will be $445,460.
Jessica J. Amenta (Mentor: Geoffrey Pitt) of Cardiology has received an award (1F30-HL112540-01) from the National Institutes of Health for a project entitled "Fibroblast growth factor homologous factors: modulators of the L-type calcium channel." Total funding will be $83,664.
William E. Kraus of Cardiology has received an award (3U01-AG022132-10S1) from the National Institutes of Health for a project entitled "CALERIE Year 10 Supplement." Total funding will be $2,595,965.
Thomas J. Povsic of Cardiology has received a sub-award (5K23-HL092297-04) through the University of Texas - Southwestern for a project entitled "Blood Pressure and Endothelial Cell Dysfunction Study." Total funding will be $6,250.
Brittany N. Bohinc (Mentor: Manal F. Abdelmalek of Gastroenterology) has received an award from the Endocrine Fellows Foundation for a project entitled "The Association of Serum Thyroid Hormone Pattern Abnormalities, Hepatic Tissue Thyroid Hypofunction, and Gene Expression of Potential Regulators of Intracellular Thyroid Hormone Concentration With Severity of Non-Alcoholic Fatty Liver Disease." Total funding will be $15,000.
Kenneth E. Schmader of Geriatrics has received a sub-award (Hartford/ASP) through the Wake Forest University Health Sciences for a project entitled "Integrating Geriatrics Into the Subspecialties of Internal Medicine: Capitalizing on Forward Momentum." Total funding will be $99,922.
Thomas L. Ortel of Hematology has received a sub-award (HHSN-268200800003C-) through the
University of Pennsylvania for a project entitled "Clinical Site Participation in Clarification of Optimal Anticoagulation through Genetics (COAG) Clinical Trial." Total funding will be $32,402.
Wendy A. Prudhomme-O'Meara of Infectious Disease has received an award (1 R03-
AI099667-01) from the National Institutes of Health for a project entitled "Serology as a measure of exposure and duration of infection in malaria trials." Total funding will be $126,000.
Yutao Liu of Medical Genetics has received an award from the North Carolina Biotechnology Center for a project entitled "Duke Acquisition of a Mid-range DNA sequencer for Molecular Genetics Core." Total funding will be $101,000.
Nicole Calakos of Neurology has received an award from the Tyler's Hope for a Dystonia Cure Inc. for a project entitled "Novel high-throughput approach to screening for modifiers of TorsinA pathology." Total funding will be $50,000.
Mark A. Stacy of Neurology has received an award from the Parkinson's Disease Foundation for a project entitled "Impulse Control Disorders in Parkinson's Disease." Total funding will be $15,000.
Claude A. Piantadosi of Pulmonary has received an award (EP-12D000116) from the Environmental Protection Agency for a project entitled "Particle-Associated Lung Injury in Mice With and Without Expression of Neutrophil Elastase and nrf 2."
Mark P. Steele of Pulmonary has received a sub-award (7R01-HK097163-03) through the University of Colorado - Denver for a project entitled "Univ of Colorado-Duke subcontract: GWAS in Fibrosing Interstitial Lung Disease." Total funding will be $178,525.
Lisa G. Criscione-Schreiber of Rheumatology has received an award from the American College of Rheumatology for a project entitled "ACR REF/Amgen/Pfizer Rheumatology Fellowship Training Award." Total funding will be $25,000.
[/tab] [tab title="Industry-sponsored clinical trials"]Thomas J. Povsic of Cardiology has received an award from Baxter Healthcare Corporation for a project entitled "Stem Cell CMI." Total funding will be $1,955,595.
Cristina Gasparetto of Cell Therapy has received an award from ImmunoGen, Inc. for a project entitled "An Open-Label Phase I Study of BB-10901 (IMGN901, huN901-DM1) in Combination with Lenalidomide and Dexamethasone in Subjects with CD56-positive Relapsed or Relapsed/Refractory Multiple Myeloma." Total funding will be $220,560.
Keith M. Sullivan of Cell Therapy has received an award from Cephalon, Inc. for a project entitled "11th Annual Fellows Research Retreat." Total funding will be $10,000.
Thomas J. Weber of Endocrinology has received an award from Kyowa Hakko Kirin Pharma Co, Ltd. for a project entitled "KRN23 INT 002 Rollover study." Total funding will be $54,031.
Andrew J. Muir of Gastroenterology has received an award from Pharmasset Inc for a project entitled "Fission Phase 3 PSI-7977 and Ribavirin vs Pagylated Interferon and Ribavirin study." Total funding will be $31,872.
Andrew J. Muir of Gastroenterology has received an award from Bristol-Myers Squibb for a project entitled "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C." Total funding will be $87,968.
Andrew J. Muir of Gastroenterology has received an award from Bristol-Myers Squibb for a project entitled "Follow up study on BMS-914143 Administered for the Treatment of Chronic Hepatitis C." Total funding will be $7,269.
Mehri McKellar of Infectious Disease has received an award from Gilead Sciences, Inc. for a project entitled "GS-US-292-0102,A Phase 2, Randomized, Double-Blinded Study of the Safety & Efficacy of EVG/Cobicistat/FTC/GS-7340 Single Tablet Regimen Vs EVG/Cobicistat/FTC/TDF Single Tablet Regimen in HIV-1 Infected, Antiretroviral Treatment-Naive Adults." Total funding will be $2,500.
James R. Burke of Neurology has received an award from TransTech Pharma, Inc for a project entitled "Phase 1 study of TTP4000 in subjects with Alzheimers Disease." Total funding will be $403,200.
Aatif Husain of Neurology has received an award from UCB Pharma, Inc. for a project entitled "Frequent Non-convulsive Seizures." Total funding will be $5,999,792.
Amy P. Abernethy of Medical Oncology has received an award from Helsinn Therapeutics (U.S.), Inc. for a project entitled "Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer Cachexia (NSCLC-C): An Extension Study." Total funding will be $160,359.
Amy P. Abernethy of Medical Oncology has received an award from Helsinn Therapeutics (U.S.), Inc. for a project entitled "Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer Cachexia (NSCLC-C): A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients with NSCLC-C." Total funding will be $197,159.
Anne W. Beaven of Medical Oncology has received an award from Spectrum Pharmaceuticals, Inc for a project entitled "Relapsed - Refractory Mantle Cell Lymphoma." Total funding will be $253,297.
Anne W. Beaven of Medical Oncology has received a sub-award (Celgene) through the Hackensack University Medical Center for a project entitled "Phase I/II Study of Lenalidomide in Combin with Rituximab,Ifosfamide,Etoposide,Carboplatin as Salvage Therapy with Single Agent Lenalidomide as Maint. Therapy Post-Autologoous Stem Cell Transpl. for the Trtmt of DLBCL Patients in First Relapse." Total funding will be $95,000.
Anne W. Beaven of Medical Oncology has received an award from the UNMC Eppley Cancer Center CTO for a project entitled "A Phase I/II Study of CEOP Alternating with Pralatrexate (P) as Front Line Therapy for Patients with Stage II (bulky), III and IV Peripheral T-Cell Non-Hodgkin's Lymphoma Followed by BEAM and Autologous Hematopoietic Stem Cell Transplantation." Total funding will be $63,440.
Michael A. Morse of Medical Oncology has received an award from Prometheus Labs, Inc. for a project entitled "Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response In Malignancy." Total funding will be $49,366.
Neal E. Ready of Medical Oncology has received an award from Bristol-Myers Squibb for a project entitled "A Multi-arm Phase I Study of BMS-936558 in Combination with Gemcitabine/Cisplatin, Pemtrexed/Cisplatin, or Carboplatin/Paclitaxelin Subjects with Treatment-Naive Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)."
Ivan Spasojevic of Medical Oncology has received an award from BioMimetix Pharmaceutical, Inc. for a project entitled "SRA." Total funding will be $200,000.
John H. Strickler of Medical Oncology has received an award from Daiichi Pharmaceutical Corporation for a project entitled "A phase I open label single sequence crossover study assessing the effect of trivanitinib (ARQ 197) on the pharmacokinetics of Omeprazole/S-Warfarin/caffeine/Midazolam and Digoxin in cancer subjects." Total funding will be $230,864.
Scott M. Palmer of Pulmonary has received a sub-award (DCRI Site Agmt - Gilead) through Gilead Sciences, Inc. for a project entitled "Treatment of Early Bronchiolitis Obliterans Syndrome after Lung Transplantation - Pro00030191."
Megan E. Clowse of Rheumatology has received an award from UCB Pharma, Inc. for a project entitled "UCB Biosciences, Inc. Epratuzumab SL0012, A Phase 3, Multicenter, Open-Label, Extension Study (EMBODY 4)." Total funding will be $238,949.[/tab] [/tabs]